Expanding Access to Home-Based Palliative Care
This study will test the effectiveness of integrating an evidence-based model of home-based palliative (HBPC) within primary care clinics on patient and caregiver outcomes. The investigators will conduct a randomized controlled trial, randomizing 1,155 seriously ill patients (and approximately 884 family caregivers) who receive primary care from 30-40 regional accountable care organizations (ACOs) in California to one of two study groups: HBPC or enhanced usual care (EUC). Follow-up data will be collected via telephone surveys with patients at 1- and 2-months and with caregivers at 1- and 2-months, and, as appropriate, following the death of the patient.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Sep 22, 2025 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Southern California
- Interventions being studied
- Other: Home-based palliative care; Other: Enhanced usual care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
1. 18 years of age or older; 2. diagnosis of HF, COPD, or advanced cancer; 3. one or more hospitalizations or ED visits in the previous year; 4. an Australia-Modified Karnofsky Performance Scale score of 70% or less; and 5. English- or Spanish-speaking.
1. is receiving hospice care; 2. has end-stage renal disease; and/or 3. lives in a nursing home.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- USC Davis School of GerontologyLos Angeles, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 22, 2025. Always confirm current availability with the study team.